Literature DB >> 26457911

Boosting humoral and cellular immunity to pneumococcus by vaccination before and just after autologous transplant for myeloma.

F L Locke1,2, M Menges1, T Nishihori1,2, C Nwoga1, M Alsina1,2, C Anasetti1,2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26457911      PMCID： PMC5726387          DOI： 10.1038/bmt.2015.239

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  12 in total

1.  Use of an inactivated varicella vaccine in recipients of hematopoietic-cell transplants.

Authors:  Atsuko Hata; Hideomi Asanuma; Mary Rinki; Margaret Sharp; Ruby M Wong; Karl Blume; Ann M Arvin
Journal:  N Engl J Med       Date:  2002-07-04       Impact factor: 91.245

2.  Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective.

Authors:  Marcie Tomblyn; Tom Chiller; Hermann Einsele; Ronald Gress; Kent Sepkowitz; Jan Storek; John R Wingard; Jo-Anne H Young; Michael J Boeckh; Michael A Boeckh
Journal:  Biol Blood Marrow Transplant       Date:  2009-10       Impact factor: 5.742

Review 3.  Immune reconstitution and immunotherapy after autologous hematopoietic stem cell transplantation.

Authors:  T Guillaume; D B Rubinstein; M Symann
Journal:  Blood       Date:  1998-09-01       Impact factor: 22.113

Review 4.  Beyond consolidation: auto-SCT and immunotherapy for plasma cell myeloma.

Authors:  N Lendvai; A D Cohen; H J Cho
Journal:  Bone Marrow Transplant       Date:  2015-03-09       Impact factor: 5.483

5.  Restoration of immunity in lymphopenic individuals with cancer by vaccination and adoptive T-cell transfer.

Authors:  Aaron P Rapoport; Edward A Stadtmauer; Nicole Aqui; Ashraf Badros; Julio Cotte; Lisa Chrisley; Elizabeth Veloso; Zhaohui Zheng; Sandra Westphal; Rebecca Mair; Nina Chi; Bashi Ratterree; Mary Francis Pochran; Sabrina Natt; Joanne Hinkle; Cheryl Sickles; Ambika Sohal; Kathleen Ruehle; Christian Lynch; Lei Zhang; David L Porter; Selina Luger; Chuanfa Guo; Hong-Bin Fang; William Blackwelder; Kim Hankey; Dean Mann; Robert Edelman; Carl Frasch; Bruce L Levine; Alan Cross; Carl H June
Journal:  Nat Med       Date:  2005-10-16       Impact factor: 53.440

6.  Protective antibody responses to pneumococcal conjugate vaccine after autologous hematopoietic stem cell transplantation.

Authors:  Joseph H Antin; Eva C Guinan; David Avigan; Robert J Soiffer; Robin M Joyce; Victoria J Martin; Deborah C Molrine
Journal:  Biol Blood Marrow Transplant       Date:  2005-03       Impact factor: 5.742

7.  Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes.

Authors:  Mark E Dudley; John R Wunderlich; Paul F Robbins; James C Yang; Patrick Hwu; Douglas J Schwartzentruber; Suzanne L Topalian; Richard Sherry; Nicholas P Restifo; Amy M Hubicki; Michael R Robinson; Mark Raffeld; Paul Duray; Claudia A Seipp; Linda Rogers-Freezer; Kathleen E Morton; Sharon A Mavroukakis; Donald E White; Steven A Rosenberg
Journal:  Science       Date:  2002-09-19       Impact factor: 47.728

8.  Cross-immunogenicity of pneumococcal group 9 capsular polysaccharides in adult volunteers.

Authors:  S C Szu; C J Lee; J C Parke; G Schiffman; J Henrichsen; R Austrian; S C Rastogi; J B Robbins
Journal:  Infect Immun       Date:  1982-03       Impact factor: 3.441

9.  Vaccination with dendritic cell/tumor fusions following autologous stem cell transplant induces immunologic and clinical responses in multiple myeloma patients.

Authors:  Jacalyn Rosenblatt; Irit Avivi; Baldev Vasir; Lynne Uhl; Nikhil C Munshi; Tami Katz; Bimalangshu R Dey; Poorvi Somaiya; Heidi Mills; Federico Campigotto; Edie Weller; Robin Joyce; James D Levine; Dimitrios Tzachanis; Paul Richardson; Jacob Laubach; Noopur Raje; Vassiliki Boussiotis; Yan Emily Yuan; Lina Bisharat; Viki Held; Jacob Rowe; Kenneth Anderson; Donald Kufe; David Avigan
Journal:  Clin Cancer Res       Date:  2013-05-17       Impact factor: 12.531

10.  A human memory T cell subset with stem cell-like properties.

Authors:  Luca Gattinoni; Enrico Lugli; Yun Ji; Zoltan Pos; Chrystal M Paulos; Máire F Quigley; Jorge R Almeida; Emma Gostick; Zhiya Yu; Carmine Carpenito; Ena Wang; Daniel C Douek; David A Price; Carl H June; Francesco M Marincola; Mario Roederer; Nicholas P Restifo
Journal:  Nat Med       Date:  2011-09-18       Impact factor: 53.440
View more
  4 in total

1.  Safety and reactogenicity of the recombinant zoster vaccine after allogeneic hematopoietic cell transplantation.

Authors:  Emily Baumrin; Natalie E Izaguirre; Bruce Bausk; Monica M Feeley; Camden P Bay; Qiheng Yang; Vincent T Ho; Lindsey R Baden; Nicolas C Issa
Journal:  Blood Adv       Date:  2021-03-23

2.  Effect of Recombinant Zoster Vaccine on Incidence of Herpes Zoster After Autologous Stem Cell Transplantation: A Randomized Clinical Trial.

Authors:  Adriana Bastidas; Javier de la Serna; Mohamed El Idrissi; Lidia Oostvogels; Philippe Quittet; Javier López-Jiménez; Filiz Vural; David Pohlreich; Tsila Zuckerman; Nicolas C Issa; Gianluca Gaidano; Je-Jung Lee; Sunil Abhyankar; Carlos Solano; Jaime Perez de Oteyza; Michael J Satlin; Stefan Schwartz; Magda Campins; Alberto Rocci; Carlos Vallejo Llamas; Dong-Gun Lee; Sen Mui Tan; Anna M Johnston; Andrew Grigg; Michael J Boeckh; Laura Campora; Marta Lopez-Fauqued; Thomas C Heineman; Edward A Stadtmauer; Keith M Sullivan
Journal:  JAMA       Date:  2019-07-09       Impact factor: 56.272

Review 3.  Cellular Immune Response after Vaccination in Patients with Cancer-Review on Past and Present Experiences.

Authors:  Maria Madeleine Rüthrich; Nicola Giesen; Sibylle C Mellinghoff; Christina T Rieger; Marie von Lilienfeld-Toal
Journal:  Vaccines (Basel)       Date:  2022-01-25

4.  Immunogenicity and safety of the 13-valent pneumococcal conjugate vaccine in patients with immunocompromising conditions: a review of available evidence.

Authors:  Erica Chilson; Daniel A Scott; Beate Schmoele-Thoma; Wendy Watson; Mary M Moran; Raul Isturiz
Journal:  Hum Vaccin Immunother       Date:  2020-06-12       Impact factor: 3.452
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.